Search

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Our Company Investors

Investors

Announcements
06-Apr-2023Intimation of revision of Credit Rating
30-Mar-2023Intimation of Conversion of the Company
21-Mar-2023Intimation of Trading Window Closure
17-Feb-2023Newspaper Publication of Financial Results-Dec 2022
13-Feb-2023Certificate of Interest Payment
08-Feb-2023Intimation of Resignation of Director – Mr. G V Sanjay Reddy
08-Feb-2023Intimation of Resignation of Director – Mr. Adam Richard Dawson
08-Feb-2023Notice of Board Meeting-13.02.2023
27-Jan-2023Proceedings of EGM
25-Jan-2023Outcome of the Board Meeting – 25.01.2023
10-Jan-2023Intimation of Record Date for Interest Payment
21-Dec-2022Intimation of Trading Window Closure
02-Dec-2022Intimation of Appointment of Director in EGM-Ms. Anita Ramachandran
02-Dec-2022Proceedings of EGM
09-Nov-2022Newspaper Publication of Financial Results dated 07.11.2022_Sep 2022
07-Nov-2022Intimation of ESOP Plan 2022
07-Nov-2022Intimation of Appointment of Director-Ms. Anita Ramachandran
02-Nov-2022Notice of Board Meeting-07.11.2022 & 08.11.2022
21-Sep-2022 Intimation of Trading Window Closure
24-Aug-2022 Proceedings of 21st AGM
08-Aug-2022 Newspaper Publication of Financial Results dated 05.08.2022_June 2022
28-Jul-2022 Notice of Board Meeting-03.08.2022
22-Jun-2022 Intimation of Trading Window Closure
10-Jun-2022 Intimation of Approval of Composite Scheme
10-Jun-2022 Intimation of Resignation of Director – Mr. Sahajbir Singh
03-Jun-2022 Intimation of Resignation of Director
30-May-2022 Newspaper Publication of Financial Results dated 28.05.2022_May 2022
23-May-2022 Notice of Board Meeting – 26.05.2022
12-May-2022 Statement of Utilization of Issue Proceeds of NCDs
23-Mar-2022 Intimation of Trading Window Closure
15-Mar-2022 Intimation of Policy for fair disclosure of Unpublished Price Sensitive Information (UPSI)
Financial Results
December-2022 Financial Result – December 2022
September-2022 Financial Result – September 2022
June-2022 Financial Result – June 2022
March-2022 Revised Financial Result – March 2022
March-2022 Financial Result – March 2022
Annual Reports

Annual Report 2021-22

Annual Returns

Annual Return 2021-22

Policies

Policy for Dividend Distribution

Policy for Preservation of Documents

Code of Conduct for Prevention of Insider Trading

Policy for fair disclosure of Unpublished Price Sensitive Information (UPSI)

Code of Conduct for Board of Directors and Senior Management

Policy on Determining Materiality for Disclosures

Policy on Material Subsidiaries

Policy on Materiality of and on dealing with RPTs

Whistle Blower Policy

Board Diversity Policy

Corporate Social Responsibility (CSR) Policy

Nomination and Remuneration Policy

Risk Management Policy

Credit Ratings
03-Apr-2023 Credit Rating_NCD_75 Crore
03-Apr-2023 Credit Rating_NCD_225 Crore
07-Apr-2022 Credit Rating_NCD_225 Crore
07-Apr-2022 Credit Rating_NCD_75 Crore
02-Feb-2022 Credit Rating_NCD_225 Crore
02-Feb-2022 Credit Rating_NCD_75 Crore
Investor Grievances

Mr. Ramakrishna Kasturi
Company Secretary, Director – Finance & Compliance
Aragen Life Sciences Pvt. Ltd.
28 A, IDA Nacharam
Hyderabad 500 076, India
+91 40 6692 9999
compliances@aragen.com

Debenture Trustee

Ms. Paridhi Doshi
IDBI Trusteeship Services Limited
Asian Building, Ground Floor
17, R. Kamani Marg, Ballard Estate
Mumbai-400001, India
+91 22 40807 000
itsl@idbitrustee.com